Borski Fund ^Investors

Borski Fund is a Venture Capital investment firm located in Amsterdam, Noord-Holland, The Netherlands. Founded on January 1, 2019, the firm operates primarily in the European Union (EU), Europe, Middle East, and Africa (EMEA) regions. With a focus on biotech, pharma, and Biomed sectors, Borski Fund has made notable investments in companies such as Prolira, the makers of DeltaScan®, a medical device used for the early detection of delirium in intensive care patients. The fund's strategic investments in the healthcare industry demonstrate its commitment to supporting innovative solutions in the field.